Eli Lilly And Co. (LLY) News Headlines

▮ More

Date

Headline

6/20/2022 9:25:07 PM Innovent : China Approves TYVYT Combination As Treatment For Esophageal Squamous Cell Carcinoma

6/14/2022 12:41:00 PM Lilly To Participate In Goldman Sachs Global Healthcare Conference At 1:40 PM ET

6/14/2022 3:39:14 AM FDA Approves First Medicine Ever For Alopecia Areata

6/14/2022 1:47:24 AM FDA Approves Lilly's Olumiant As First Systemic Treatment For Alopecia

6/7/2022 1:14:10 AM Lilly Reports Positive Data From Lebrikizumab Atopic Dermatitis Monotherapy Trials

6/7/2022 12:48:07 AM Lilly Announces Positive Topline Results From Phase 3 Clinical ADvocate 1 And 2 Trials

6/5/2022 11:19:22 PM Lilly : Jardiance Decreases Risk Of Hospitalization For Heart Failure By 50% In Type 2 Diabetes

5/25/2022 9:23:32 PM Lilly To Invest $2.1 Bln In New Manufacturing Sites In Indiana

5/24/2022 7:30:11 AM Eli Lilly And Co. To Present At UBS Global Healthcare Conference; Webcast At 8:30 AM ET

5/24/2022 4:20:00 AM Lilly: One-half Of Mirikizumab Patients Achieves Clinical Remission At One Year In Phase 3 Study

5/24/2022 3:07:37 AM Lilly: 50% Of Patients With UC Treated With Mirikizumab Achieved Clinical Remission At 1 Yr In Phase 3 Study

5/20/2022 8:29:07 AM Lilly : CHMP Issues Positive Opinion For Olumiant For Severe Alopecia Areata Treatment

5/20/2022 8:19:00 AM Lilly : CHMP Issues Positive Opinion For OLUMIANT For Treatment Of Adults With Severe Alopecia Areata

5/13/2022 9:58:03 PM FDA Approves Lilly's Mounjaro Injection For Type 2 Diabetes Treatment

5/11/2022 7:04:22 AM Eli Lilly, Incyte Announce FDA Approval Of OLUMIANT For Hospitalized Patients With COVID-19

5/11/2022 6:51:49 AM Lilly And Incyte: FDA Approves OLUMIANT For Certain Hospitalized Patients With COVID-19

5/6/2022 3:00:17 PM Eli Lilly And Co. Elects Mary Lynne Hedley To Board Of Directors

5/2/2022 4:02:01 PM Lilly Declares Q2 Dividend Of $0.98/share, Payable June 10/ Record May 16

5/2/2022 3:40:09 PM Eli Lilly And Co. (LLY) Declares $ 0.98 Dividend for Q2 22, Record Date 5/16/2022

4/28/2022 8:04:49 AM Lilly: Tirzepatide In SURMOUNT-1 Trial Delivers Superior Weight Loss In Adults